Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹10.65
Market cap
₹238.8 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-1.0×Sector 47.4×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:11 IST BSE
Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences Limited has announced the appointment of Dr. Gunmala Suri as a Director. Additionally, three other directors have been re-appointed to the Board.

21:19 IST BSE
Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences Limited has appointed Dr. Gunmala Suri as an Additional Director, effective August 15, 2026.

18:18 IST NSE
Management Change

Nectar Lifesciences Management Change

Dr. Surulichamy Senthilkumar has resigned as a Non-Executive Non-Independent Director of Nectar Lifesciences Ltd., effective August 06, 2026, due to personal reasons.

16:48 IST NSE
Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences appointed Kfin Technologies Limited as its new Registrar and Share Transfer Agent. This follows the withdrawal of a proposal for Alankit Assignments Limited.